Found: 4
Select item for more details and to access through your institution.
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00687-7
- By:
- Publication type:
- Article
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1021, doi. 10.1007/s10637-022-01287-7
- By:
- Publication type:
- Article
Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01095-1
- By:
- Publication type:
- Article
Construction and characterization of an infectious replication competent clone of porcine endogenous retrovirus from Chinese miniature pigs.
- Published in:
- Virology Journal, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1743-422X-10-228
- By:
- Publication type:
- Article